Platelet Rich Plasma Injections for Non-Wound Injections
JE · Effective Jan 23, 2022
4 active Medicare policies list G0465, and 5 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
JE · Effective Jan 23, 2022
JF · Effective Jan 23, 2022
National · Effective Jul 1, 2023
National · Effective Sep 11, 2025
5 policies from 5 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of G0465 |
|---|---|---|
| TRANS.00035 Therapeutic use of Stem Cells, Blood and Bone Marrow Products | Oct 1, 2025 | Not covered |
| Policy | Effective | Status of G0465 |
|---|---|---|
| Prolotherapy and Platelet Rich Plasma Therapies | Jan 1, 2026 | Covered |
| Policy | Effective | Status of G0465 |
|---|---|---|
| Prolotherapy and Platelet Rich Plasma Therapies |
| Jan 1, 2026 |
| Covered |
| Policy | Effective | Status of G0465 |
|---|---|---|
| Prolotherapy and Platelet Rich Plasma Therapies | Jan 1, 2026 | Covered |
| Policy | Effective | Status of G0465 |
|---|---|---|
| Platelet Rich Plasma Therapies | Not recorded | Covered |